🇺🇸 ciclosporine in United States
193 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 20 April 2025 – 20 April 2026
- Total reports: 193
Most-reported reactions
- Drug Ineffective — 38 reports (19.69%)
- Off Label Use — 37 reports (19.17%)
- Acute Graft Versus Host Disease — 18 reports (9.33%)
- Pyrexia — 17 reports (8.81%)
- Condition Aggravated — 16 reports (8.29%)
- Drug Interaction — 15 reports (7.77%)
- Acute Kidney Injury — 14 reports (7.25%)
- Chronic Graft Versus Host Disease — 13 reports (6.74%)
- Neutropenia — 13 reports (6.74%)
- Septic Shock — 12 reports (6.22%)
Other Immunology approved in United States
Frequently asked questions
Is ciclosporine approved in United States?
ciclosporine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for ciclosporine in United States?
Hospices Civils de Lyon is the originator. The local marketing authorisation holder may differ — check the official source linked above.